Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Clicks: 563
ID: 111365
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 9 articles by views in the lancet oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Fondazione Italiana Linfomi.
Reference Key
a2017therituximab-dose-dense Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balzarotti M;Merli F;Gaidano G;Pavone V;Rigacci L;Zaja F;D'Arco A;Cascavilla N;Russo E;Castellino A;Gotti M;Congiu AG;Cabras MG;Tucci A;Agostinelli C;Ciccone G;Pileri SA;Vitolo U;;
Journal the lancet oncology
Year 2017
DOI
DOI not found
URL
https://www.pubmed.gov/28668386/
Keywords
transplantation National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male middle aged Comparative Study risk factors Clinical Trial Phase III Randomized Controlled Trial Antibodies Monoclonal Multicenter Study follow-up studies survival rate autologous induction chemotherapy pmid:28668386 doi:10.1016/s1470-2045(17)30444-8 annalisa chiappella maurizio martelli umberto vitolo murine-derived / administration & dosage murine-derived / adverse effects antineoplastic combined chemotherapy protocols / administration & dosage* antineoplastic combined chemotherapy protocols / adverse effects carmustine / administration & dosage consolidation chemotherapy cyclophosphamide / administration & dosage cyclophosphamide / adverse effects cytarabine / administration & dosage dexamethasone / administration & dosage disease-free survival doxorubicin / administration & dosage doxorubicin / adverse effects etoposide / administration & dosage hematologic diseases / chemically induced intention to treat analysis lymphoma large b-cell diffuse / therapy* melphalan / administration & dosage mitoxantrone / administration & dosage prednisone / administration & dosage prednisone / adverse effects rituximab / administration & dosage* stem cell transplantation* / adverse effects vincristine / administration & dosage vincristine / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.